“…The present investigation was designed as a non‐interventional 5‐year follow‐up clinical trial based on two prospective studies with patients treated at the Clinic of Fixed and Removable Prosthodontics and Dental Material Science Center of Dental Medicine, University of Zürich, Switzerland (Ebler, Ioannidis, Jung, Hammerle, & Thoma, ; Gamper et al., ; local ethics committee numbers: 2013‐0121, 2014‐0201). The patients had been treated using either one of four implant systems: AST (Astra Tech Osseospeed ® ; ASTRA TECH implant system, DENTSPLY Implants, Mölndal, Sweden), STMBL (Straumann Bone Level Implants ® ; Institute Straumann AG, Basel, Switzerland), BRA (Brånemark MKIII or MKIV; Nobel Biocare, Zürich, Switzerland) and STMTL (Institute Straumann AG).…”